Oliver Luxxe Assets’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-47,067
| Closed | -$2.73M | – | 167 |
|
|
2023
Q3 | $2.73M | Sell |
47,067
-17,294
| -27% | -$1M | 0.7% | 51 |
|
|
2023
Q2 | $4.12M | Buy |
64,361
+340
| +0.5% | +$21.7K | 1.03% | 34 |
|
|
2023
Q1 | $4.44M | Buy |
64,021
+1,607
| +3% | +$111K | 1.17% | 30 |
|
|
2022
Q4 | $4.49M | Buy |
62,414
+910
| +1% | +$65.5K | 1.25% | 24 |
|
|
2022
Q3 | $4.37M | Buy |
61,504
+2,933
| +5% | +$208K | 1.37% | 13 |
|
|
2022
Q2 | $4.51M | Buy |
+58,571
| New | +$4.51M | 1.33% | 19 |
|
|
2021
Q4 | – | Sell |
-47,855
| Closed | -$2.83M | – | 200 |
|
|
2021
Q3 | $2.83M | Buy |
47,855
+13,361
| +39% | +$791K | 0.78% | 45 |
|
|
2021
Q2 | $2.31M | Sell |
34,494
-1,214
| -3% | -$81.1K | 0.63% | 60 |
|
|
2021
Q1 | $2.25M | Buy |
35,708
+865
| +2% | +$54.6K | 0.68% | 54 |
|
|
2020
Q4 | $2.26M | Sell |
34,843
-15,295
| -31% | -$994K | 0.71% | 53 |
|
|
2020
Q3 | $3.02M | Buy |
50,138
+1,391
| +3% | +$83.9K | 1.13% | 29 |
|
|
2020
Q2 | $2.87M | Buy |
48,747
+377
| +0.8% | +$22.2K | 1.51% | 23 |
|
|
2020
Q1 | $2.82M | Buy |
+48,370
| New | +$2.82M | 1.77% | 15 |
|
|
2019
Q1 | – | Sell |
-39,170
| Closed | -$2.04M | – | 114 |
|
|
2018
Q4 | $2.04M | Buy |
39,170
+5,875
| +18% | +$305K | 1.37% | 34 |
|
|
2018
Q3 | $2.08M | Buy |
+33,295
| New | +$2.08M | 1.18% | 40 |
|